900m lives depend on livestock

GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline

About GALVmed

Neurocysticercosis, a human disease transmitted from pigs with porcine cysticercosis (PC), causes 30% of human epilepsy cases in the developing world.

The disease is estimated to cause around 5 million human cases and 50,000 human deaths each year.

This is a disease that affects the poor and those who have neurocysticercosis are often stigmatised in their communities.

The first-ever licensed PC vaccine became available in India at the end of 2016 at US $1 for 2 doses to vaccinate a pig.

Tackling the major cause of epilepsy in the developing world

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Market development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.


Poultry vaccination pays off for Indian farmers as demand increases

Access to a vaccine for Newcastle Disease (ND) has transformed the lives of communities in the Mayurbhanj district of Odisha state.

Local inhabitants, who have traditionally bred poultry, would often experience the death of their flock …

Newcastle Disease vaccination in India creates new job opportunities as well as saving poultry

Newcastle Disease (ND) vaccinators in Mayurbhanj district of Odisha state in India can today look towards bright prospects. The demand for their services has not only spawned new employment opportunities within their locales, but has …

Regional sensitisation workshop on Newcastle Disease control in village poultry in West Africa

A two-day workshop on Newcastle disease (ND) control in West and Central Africa brought together 38 representatives from the government and private sectors to discuss key challenges and potential interventions in the vaccine delivery and …